Akthelia
VerifiedAkthelia is focused on the discovery and development of novel antimicrobial therapeutics.
Company register number 6105026440
Reykjavík Capital Region (HQ)
EUR | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 |
---|---|---|---|---|---|---|---|
Revenues | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
Profit | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
% profit margin | (5 %) | - | - | - | - | - | - |
EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
Source: Dealroom estimates
Get premium to view all results
Date | Investors | Amount | Round |
---|---|---|---|
- | investor investor | $0.0 | round |
investor | $0.0 | round | |
investor | $0.0 | round | |
investor | $0.0 | round | |
N/A | $0.0 | round | |
* | N/A | Grant | |
Total Funding | 000k |
Related Content
Recent News about Akthelia
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.